 Cerevel Therapeutics Holdings, Inc. NASDAQ:CERE Q2 2022 Earnings Conference Call August 1, 2022 8:00 AM ET Company Participants Matt Calistri - Vice President of Corporate Strategy and Investor Relations Tony Coles - Chairperson and Chief Executive Officer Ray Sanchez - Chief Medical Officer John Renger - Chief Scientific Officer Mark Bodenrader - Interim Chief Financial Officer A. Ceesay - President Conference Call Participants Michael Yee - Jefferies Matthew Harrison - Morgan Stanley Paul Matteis - Stifel Tiffany Sun - JPMorgan Douglas Tsao - H.C. 